Globalworld globe
United Kingdom
North America
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
    • Medical Devices
    • Veterinary
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

Board of Directors/Management

The success of any company is through its management and leadership. MVP has a team of dedicated and experienced management specialists who seek new business opportunities and operate an efficient and profitable company. The company is overseen by its Board of Directors who offer an extensive knowledge base across business, finance and the health industry, who together, make the necessary decisions for the welfare of MVP’s shareholders and the growth of the company.

Management

Brent MacGregor
Chief Executive Officer

Mark Edwards
Chief Financial Officer and Company Secretary

Matthew Cramer
Chief of Operations and Supply Chain

Scott Courtney
Chief Scientific Officer

Neil Issa
Head of Quality

Michelle Bradney
Head of Medical Affairs

Chi Wai Ng
Head of Regulatory Affairs

Wayne Pearce
Head of Production

Thomas Materia
Sales & Marketing

Tara Collier
Human Resources

Board of Directors

Gordon Naylor
Non-Executive Chairman

Gordon has enjoyed a long and successful international business career.  For over 30 years he was a key part of the internationalisation of the CSL Group, a global specialty biotechnology company that was established in Australia and grew to become Australia’s largest public company.  Gordon held a range of business and functional leadership roles within CSL including Chief Financial Officer.  At the time of his retirement from CSL, he was the President of Seqirus where he led the 3-year turnaround of that business into one of the most successful vaccine companies in the world.  In 2016 Seqirus was highly unprofitable with a turnover of circa $700m.  By 2019 the business generated circa $150m EBIT from a turnover of $1.2b.

Gordon holds a Bachelor of Engineering (Honours), a Graduate Diploma in Computer Science and an MBA as well as being a CPA and a graduate of the Australian Institute of Company Directors.

David Williams, B.Ec (Hons), M.Ec, FAICD
Non-Executive Director

David is Managing Director of Kidder Williams Ltd, with over 30 years experience in the investment banking sector. He is also Chairman of PolyNovo Ltd and RMA Global Limited.

Max Johnston
Non-Executive Director

Max was appointed a Director of the company with effect from November 2012. Max is also non-executive director of PolyNovo Limited, Bard1 Sciences Limited and is also a Non-executive Director and Chairman of Auscann Group Holdings Limited.

For 11 years he was President and Chief Executive Officer of Johnson & Johnson Pacific and an Executive Director of Johnson & Johnson.

Max has also held several prominent industry roles as a past President of ACCORD Australasia Limited, a former Vice Chairman of the Australian Food and Grocery Council and a former member of the board of ASMI. Max has had extensive overseas experience during his career in leading businesses in both Western and Central-Eastern Europe, Africa as well as Asia-Pacific.

Leon Hoare
Non-Executive Director

Mr Hoare is the Managing Director of Lohmann & Rauscher (Australia and New Zealand), a private EU based medical device company. Previously, he was Managing Director of Smith & Nephew (Aus/NZ). which is one of the company’s largest global subsidiaries outside of the USA. Until 2014 he served as President of Smith & Nephew’s Asia Pacific Advanced Wound Management (AWM) business for 5 years and was a member of the Global Executive Management for the AWM Division. In his 24 years with Smith & Nephew, he also held roles in Marketing, Divisional and General Management. Mr Hoare’s career also included a senior role at Bristol-Myers Squibb in surgical products, and Vice-Chair of Australia’s peak medical device body, Medical Technology Association of Australia. Leon is also a Non-executive Director of PolyNovo Limited (ASX: PNV).

Leon’s 30 years of healthcare industry experience, spanning multiple medical technologies, and management of all aspects of a major market-leading medical device company, coupled with extensive experience in Asia, will add depth to the Board of Directors.

Philip Powell
Non-Executive Director

Philip, a Chartered Accountant, has an extensive finance background and commenced working in investment banking in 1996 at Hambros Corporate Finance following ten years industry experience in senior finance roles with ASX listed public company OAMPS Limited. Prior to these roles, Philip worked for ten years within the Assurance Division at Arthur Andersen & Co.

From January 2006 to July 2013 Philip was an Executive Director at Corporate Finance Advisory firm Kidder Williams. Philip is also a Director of PolyNovo Limited (ASX:PNV) and RMA Global Limited (ASX:RMY).

Philip is also Chairman of the MDI Audit and Risk Committee.

Christine Emmanuel
Non-Executive Director

Christine has a Bachelor of Science and major in Economics (Hons: Chem) from Monash University, Certificate in Intellectual Property Law from Queen Mary College, University of London, Masters of Enterprise from Melbourne University and is a member of the Chartered Institute of Patent Attorneys UK.  Christine has also been on the Board of the Institute of Patent and Trade Mark Attorneys of Australia since 2010.

Christine is an experienced patent and trademark attorney, and a business development professional having more than 30 years’ experience locally and internationally. Christine is also a Non-executive Director of PolyNovo Limited (ASX: PNV).

 

  • Investors/Media
  • Financial Reports
  • Board of Directors/Management
  • Media Centre
  • Corporate Governance
  • Diversity Policy
  • Share Trading Policy
  • Interviews/Analyst Reports

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • FY21 Half Year Report and Accounts

    26 February 2021 ASX ANNO...

  • MVP Completes $25m Placement

    14 December 2020 ASX ANNO...

  • EU Transition and Trading Update

    3 December 2020 ASX ANNOU...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me


Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: mdi@medicaldev.com
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: medinf@medicaldev.com

Email Newsletter

Sign up to our newsletter to receive MDI corporate, investor  & media news.